Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Tumor epidermal growth factor receptor genotype and depression in stage IV non-small cell lung cancer.

Pirl WF, Traeger L, Greer JA, Bemis H, Gallagher E, Lennes I, Sequist L, Heist R, Temel JS.

Oncologist. 2011;16(9):1299-306. doi: 10.1634/theoncologist.2011-0116. Epub 2011 Aug 1.

2.

Depression, survival, and epidermal growth factor receptor genotypes in patients with metastatic non-small cell lung cancer.

Pirl WF, Traeger L, Greer JA, Jackson V, Lennes IT, Gallagher E, Sequist L, Temel JS.

Palliat Support Care. 2013 Jun;11(3):223-9. doi: 10.1017/S1478951512001071. Epub 2013 Feb 11.

PMID:
23399428
3.

EML4-ALK rearrangement and its clinical significance in Chinese patients with advanced non-small cell lung cancer.

Wang Z, Zhang X, Bai H, Zhao J, Zhuo M, An T, Duan J, Yang L, Wu M, Wang S, Wang Y, Wu Y, Wang J.

Oncology. 2012;83(5):248-56. doi: 10.1159/000341381. Epub 2012 Sep 4.

PMID:
22964709
4.

Detection of epidermal growth factor receptor mutations in serum as a predictor of the response to gefitinib in patients with non-small-cell lung cancer.

Kimura H, Kasahara K, Kawaishi M, Kunitoh H, Tamura T, Holloway B, Nishio K.

Clin Cancer Res. 2006 Jul 1;12(13):3915-21.

5.

[Role of EGFR mutation status in patients with stage III non-squamous non-small cell lung cancer treated with chemoradiotherapy].

Li F, Bai H, Li X, Wu M, Yu R, Shi A, Yin L, Wang J, Zhu G.

Zhongguo Fei Ai Za Zhi. 2011 Sep;14(9):715-8. doi: 10.3779/j.issn.1009-3419.2011.09.03. Chinese.

6.
7.

Prognostic value of acquired resistance-related molecules in Japanese patients with NSCLC treated with an EGFR-TKI.

Uramoto H, Yamada T, Yano S, Kondo N, Hasegawa S, Tanaka F.

Anticancer Res. 2012 Sep;32(9):3785-90.

PMID:
22993320
8.

First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations.

Sequist LV, Martins RG, Spigel D, Grunberg SM, Spira A, Jänne PA, Joshi VA, McCollum D, Evans TL, Muzikansky A, Kuhlmann GL, Han M, Goldberg JS, Settleman J, Iafrate AJ, Engelman JA, Haber DA, Johnson BE, Lynch TJ.

J Clin Oncol. 2008 May 20;26(15):2442-9. doi: 10.1200/JCO.2007.14.8494. Epub 2008 May 5. Erratum in: J Clin Oncol. 2008 Jul 10;26(20):3472.

9.

Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib.

Riely GJ, Pao W, Pham D, Li AR, Rizvi N, Venkatraman ES, Zakowski MF, Kris MG, Ladanyi M, Miller VA.

Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):839-44.

10.

L858R EGFR mutation status correlated with clinico-pathological features of Japanese lung cancer.

Sasaki H, Endo K, Takada M, Kawahara M, Kitahara N, Tanaka H, Okumura M, Matsumura A, Iuchi K, Kawaguchi T, Yukiue H, Kobayashi Y, Yano M, Fujii Y.

Lung Cancer. 2006 Oct;54(1):103-8. Epub 2006 Aug 4.

PMID:
16890322
12.

Influence of chemotherapy on EGFR mutation status among patients with non-small-cell lung cancer.

Bai H, Wang Z, Chen K, Zhao J, Lee JJ, Wang S, Zhou Q, Zhuo M, Mao L, An T, Duan J, Yang L, Wu M, Liang Z, Wang Y, Kang X, Wang J.

J Clin Oncol. 2012 Sep 1;30(25):3077-83. doi: 10.1200/JCO.2011.39.3744. Epub 2012 Jul 23.

13.

Epidermal growth factor receptor mutations in plasma DNA samples predict tumor response in Chinese patients with stages IIIB to IV non-small-cell lung cancer.

Bai H, Mao L, Wang HS, Zhao J, Yang L, An TT, Wang X, Duan CJ, Wu NM, Guo ZQ, Liu YX, Liu HN, Wang YY, Wang J.

J Clin Oncol. 2009 Jun 1;27(16):2653-9. doi: 10.1200/JCO.2008.17.3930. Epub 2009 May 4.

14.

Clinical impact of switching to a second EGFR-TKI after a severe AE related to a first EGFR-TKI in EGFR-mutated NSCLC.

Takeda M, Okamoto I, Tsurutani J, Oiso N, Kawada A, Nakagawa K.

Jpn J Clin Oncol. 2012 Jun;42(6):528-33. doi: 10.1093/jjco/hys042. Epub 2012 Mar 28.

15.

[Relationship of epidermal growth factor receptor gene mutations, clinicopathologic features and prognosis in patients with non-small cell lung cancer].

Fan MJ, Li HG, Lü ZQ, Zhang HZ, Shen XM.

Zhonghua Bing Li Xue Za Zhi. 2011 Oct;40(10):679-82. Chinese.

PMID:
22321547
16.

[Detection of epidermal growth factor receptor gene mutations in advanced non-small cell lung cancer].

Wang S, Han XH, Li JL, Hu XS, Wang XY, Gui L, Zhao LD, Sun Y, Shi YK.

Zhonghua Bing Li Xue Za Zhi. 2012 Aug;41(8):530-3. doi: 10.3760/cma.j.issn.0529-5807.2012.08.005. Chinese.

PMID:
23157744
17.

EGFR mutation testing in patients with advanced non-small cell lung cancer: a comprehensive evaluation of real-world practice in an East Asian tertiary hospital.

Choi YL, Sun JM, Cho J, Rampal S, Han J, Parasuraman B, Guallar E, Lee G, Lee J, Shim YM.

PLoS One. 2013;8(2):e56011. doi: 10.1371/journal.pone.0056011. Epub 2013 Feb 28.

18.

[Detection of epidermal growth factor receptor mutations in non-small-cell lung carcinoma by direct sequencing and correlations with clinicopathological characteristics and sample types].

Sun MH, Yang F, Shen L, Zhang L, Chen Y, Cai X, Zhu XL, Zhou XY.

Zhonghua Bing Li Xue Za Zhi. 2011 Oct;40(10):655-9. Chinese.

PMID:
22321541
19.

Epidermal growth factor receptor gene mutation in non-small cell lung cancer using highly sensitive and fast TaqMan PCR assay.

Endo K, Konishi A, Sasaki H, Takada M, Tanaka H, Okumura M, Kawahara M, Sugiura H, Kuwabara Y, Fukai I, Matsumura A, Yano M, Kobayashi Y, Mizuno K, Haneda H, Suzuki E, Iuchi K, Fujii Y.

Lung Cancer. 2005 Dec;50(3):375-84. Epub 2005 Sep 30.

PMID:
16199108
20.

Clinical outcomes of advanced non-small cell lung cancer patients screened for epidermal growth factor receptor gene mutations.

Yoshida K, Yatabe Y, Park J, Ogawa S, Park JY, Shimizu J, Horio Y, Matsuo K, Mitsudomi T, Hida T.

J Cancer Res Clin Oncol. 2010 Apr;136(4):527-35. doi: 10.1007/s00432-009-0685-2. Epub 2009 Sep 24.

PMID:
19777258
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk